LCD L33912: Trigger Point Injections — First Coast
Policy LCD-L33912 · Pain Management
Trigger Point Injection coverage rules take effect Sept 6, 2026 in FL/PR/VI
Code intelligence
J2001 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code J2001.
Elevated code riskView HCPCS detail
Signal breakdown
2 shown · 2 total in platform
Risk: Elevated
0
Critical
0%
1
High
50%
1
Routine
50%
0
Low
0%
New this month
+1
alerts added in last 30 days
Effective soon
1
policies effective within 30 days
High
FDA Approval: LIDOCAINE (LIDOCAINE HYDROCHLORIDE) — Type 5 - New Formulation or New Manufacturer
Policy FDA-NDA017584 · Multi-specialty
New FDA drug approval. Coverage and billing pathway depend on the FDA label and applicable Medicare LCDs/NCDs — for very recent approvals the label may not be posted yet. Verify against the FDA label and current coverage policy before billing.
Audit documentation
Building an audit file that includes J2001?
The Tripwire Audit Pack exports 12 months of Pain Management policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Pain Management audit pack — $349One-time purchase · not a subscription